Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 50.34
(-0.57%)
CNY 50.34
(-0.57%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 509.21 Million CNY | -14.86% |
| 2022 | 598.06 Million CNY | -27.9% |
| 2021 | 829.47 Million CNY | 103.28% |
| 2020 | 408.04 Million CNY | 118.57% |
| 2019 | 186.68 Million CNY | 21.12% |
| 2018 | 154.13 Million CNY | 107.02% |
| 2017 | 74.45 Million CNY | 1018.33% |
| 2016 | 6.65 Million CNY | -43.1% |
| 2015 | 11.7 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 99.34 Million CNY | -36.76% |
| 2024 Q1 | 149.46 Million CNY | 6.55% |
| 2024 Q2 | 157.08 Million CNY | 5.1% |
| 2023 Q4 | 140.27 Million CNY | 16.19% |
| 2023 FY | 509.21 Million CNY | -14.86% |
| 2023 Q1 | 105.19 Million CNY | -8.33% |
| 2023 Q2 | 143.01 Million CNY | 35.96% |
| 2023 Q3 | 120.73 Million CNY | -15.58% |
| 2022 Q4 | 114.75 Million CNY | -31.55% |
| 2022 FY | 598.06 Million CNY | -27.9% |
| 2022 Q2 | 180.39 Million CNY | 33.36% |
| 2022 Q1 | 135.27 Million CNY | -45.04% |
| 2022 Q3 | 167.63 Million CNY | -7.07% |
| 2021 Q1 | 100.49 Million CNY | 56.1% |
| 2021 Q4 | 246.11 Million CNY | -25.69% |
| 2021 FY | 829.47 Million CNY | 103.28% |
| 2021 Q3 | 331.19 Million CNY | 118.36% |
| 2021 Q2 | 151.66 Million CNY | 50.92% |
| 2020 Q1 | 64.87 Million CNY | -33.95% |
| 2020 FY | 408.04 Million CNY | 118.57% |
| 2020 Q2 | 117.81 Million CNY | 81.6% |
| 2020 Q3 | 160.97 Million CNY | 36.63% |
| 2020 Q4 | 64.38 Million CNY | -60.0% |
| 2019 Q3 | 3.69 Million CNY | -92.5% |
| 2019 FY | 186.68 Million CNY | 21.12% |
| 2019 Q4 | 98.21 Million CNY | 2558.16% |
| 2019 Q2 | 49.24 Million CNY | 38.58% |
| 2019 Q1 | 35.53 Million CNY | 188.29% |
| 2018 Q4 | 12.32 Million CNY | 0.0% |
| 2018 FY | 154.13 Million CNY | 107.02% |
| 2017 FY | 74.45 Million CNY | 1018.33% |
| 2016 FY | 6.65 Million CNY | -43.1% |
| 2015 FY | 11.7 Million CNY | 0.0% |